Zantac, a brand name for the drug ranitidine, was a widely used and heavily prescribed over-the-counter medication used to treat heartburn, acid reflux, and other gastrointestinal conditions. It worked by reducing the production of stomach acid.
Once a leading medication in its class, Zantac’s reputation and usage plummeted in 2020 following alarming reports about its safety, leading to major legal and health concerns.
The recall and legal actions against Zantac began after the discovery of NDMA (N-Nitrosodimethylamine), a known probable carcinogen, in its formula. This raised global health alarms, with the FDA and health agencies across the world issuing warnings and recalls.
The presence of NDMA in Zantac ranitidine medications is particularly concerning due to the chemical’s link to cancer. The discovery led to rigorous scrutiny of the drug's safety and the eventual decision to withdraw it from the global market.
Research and litigation have highlighted several types of cancer that could be linked to Zantac (ranitidine) use, primarily due to its contamination with NDMA, a known carcinogen. The risks are especially pronounced for long-term users.
Reported cancers include:
Each of these cancers represents a serious health concern, and any one of them could forever alter the lives of those affected and form the basis of a legal claim against the manufacturers of Zantac.
Eligibility for filing a Zantac lawsuit hinges on a mixture of medical and legal factors, including the following:
The experienced attorneys at LevelUp Law are dedicated to providing comprehensive legal support for those affected by Zantac-related health issues. We work hard to guide and assist you through the legal process.
Our services include:
A qualified lawyer is a great asset when pursuing any type of claim for compensation.
Victims of Zantac-related cancers may be entitled to receive significant compensation, including:
Our team is determined to obtain the full range of compensation to which our clients are entitled. These damages serve to acknowledge the life-changing impact of Zantac-related illnesses.
The Zantac Multi-District Litigation (MDL) represents individuals diagnosed with cancer allegedly due to Zantac. While the initial claims in the Southern District of Florida were dismissed in December 2022, lawyers have made ongoing efforts to appeal this decision, suggesting that the legal battle surrounding Zantac is far from over.